期刊文献+

低强度复合振动联合阿仑膦酸钠对绝经后骨质疏松患者骨密度的影响研究 被引量:15

Clinical observation of low-magnitude whole-body vibration combined with Alendronate on bone mineral density in women with postmenopausal osteoporosis
下载PDF
导出
摘要 目的:观察低强度全身复合振动(whole-body vibration,WBV)联合阿仑膦酸钠(alendronate,ALE)对绝经后骨质疏松患者骨密度的影响情况。方法:选择2014年8—12月门诊绝经后骨质疏松患者60例,随机分为WBV治疗组、ALE治疗组和WBV+ALE治疗组,每组20例;WBV治疗组是给予全身低强度复合振动(振动强度为0.5—0.8g,频率为45—55Hz,每次振动30min,每天1次,每周5次,周末休息2天,共6个月);ALE治疗组是每周口服1次阿仑膦酸钠70mg;WBV+ALE治疗组是给予全身复合振动及阿仑膦酸钠治疗。然后使用双能X线吸收骨密度仪测定所有志愿者治疗前后腰椎及髋部的骨密度。结果:(1)腰椎骨密度在WBV治疗6个月后增加3.72%,ALE治疗组增加4.55%,WBV+ALE治疗组增加7.16%,三组治疗方法之间有显著性差异(P<0.05)。(2)髋部Neck骨密度,WBV治疗6个月后增加2.24%,ALE治疗组增加3.43%,WBV+ALE治疗组增加7.22%,三组治疗方法比较有显著性差异(P<0.05)。(3)大转子骨密度,WBV治疗6个月后增加2.10%,ALE治疗组增加4.90%,WBV+ALE治疗组增加7.63%,三组治疗方法之间比较有显著性差异(P<0.05)。(4)髋部Wards三角骨密度,WBV治疗6个月后增加5.00%,ALE治疗组增加7.13%,WBV+ALE治疗组增加9.04%,三组治疗方法之间比较有显著性差异(P<0.05)。结论:WBV、ALE和WBV+ALE三种治疗方法均能改善绝经后老年妇女腰椎及髋部的骨密度,其中低强度WBV联合ALE能够更好提高绝经后腰椎及髋部BMD,可以为临床上绝经后骨质疏松的防治工作提供一种新的思路。 Objective: To observe the bone mineral density for patients with postmenopausal osteoporosis treated by lowmagnitude whole-body vibration and alendronate.Method: A total of sixty postmenopausal osteoporotic women were randomly divided into three groups(WBV n=20, ALE n=20 and WBV + ALE n=20). The level of WBV applied was 0.5—0.8 g at 45—55 Hz for 6months(30min/d, 5d/week). ALE was administered in dose of 70 mg once a week. The BMD of lumbar(L2—L4), femoral neck, anter, and wards triangle region of hip was determined by dual-energy X-ray absorptiometry before and after treatment.Result:(1) The BMD in lumbar 2—4 after 6-months treatment showed that the average BMD was increased by 3.72% in WBV-group, by 4.55% in ALE-group, and by 7.16% in WBV+ALE-group. There were significant differences among three groups(P〈0.05).(2) The BMD in femoral neck after 6-months treatment showed that the average BMD was increased by 2.24% in WBV-group, by 3.43% in ALE-group, and by 7.22% in WBV+ALE-group. There were significant differences among three groups(P〈0.05).(3)The BMD in anter of hip after 6-months treatment showed that the average BMD was increased by 2.10% in WBV-group, by 4.90% in ALE-group, and by 7.63% in WBV + ALE-group. There were significant differences among three groups(P〈0.05).(4) The BMD in wards triangle region of hip after 6-months treatment showed that the average BMD was increased by 5.00% in WBV-group, by 7.13% in ALE-group, and by 9.04% in WBV+ALE-group. There were also significant differences among three groups(P〈0.05).Conclusion: Whole-body vibration, alendronate and combination treatment can increase the BMD in postmenopausal osteoporotic women, significantly. Furthermore, whole-body vibration combined with alendronate was more effective in improving the BMD in postmenopausal women.
出处 《中国康复医学杂志》 CAS CSCD 北大核心 2017年第2期182-186,共5页 Chinese Journal of Rehabilitation Medicine
基金 福建省医学创新课题资助项目(2014-CXB-31) 福建莆田市科技局资助项目(2012S01)
关键词 全身复合振动 阿仑膦酸钠 骨质疏松症 绝经后妇女 骨密度 whole-body vibration Alendronate osteoporosis postmenopausal women bone mineral density
  • 相关文献

参考文献3

二级参考文献49

  • 1林守清.雌激素对骨质疏松的防治及在骨转换中作用[J].中华医学杂志,2005,85(11):728-729. 被引量:29
  • 2叶超群,纪树荣.力学刺激在骨组织中的信号转导[J].中华物理医学与康复杂志,2005,27(12):765-767. 被引量:7
  • 3Filip RS,Zagórski J.Age and BMD related differences in biochemical markers of bone metabolism in rural and urban women from Lublin Region,Poland.Ann Agric Environ Med,2004,11:255-259. 被引量:1
  • 4Finkelstein JS,Sowers M,Greendale GA,et al.Ethnic variation in bone turnover in pre-and early perimenopausal women:effects of anthropometric and lifestyle factors.J Clin Endocrinol Metab,2002,87:3051-3056. 被引量:1
  • 5Reginster JY,Henrotin Y,Christiansen C,et al.Bone resorption in post-menopausal women with normal and low BMD assessed with biochemical markers specific for telopeptide derived degradation products of collagen type I.Calcif Tissue Int,2001,69:130-137. 被引量:1
  • 6Zaninotto M,Bernardi D,Ujka F,et al.A proposal for standardizing urine collections for bone resorption markers measurement.J Clin Lab Anal,1998,12:145-149. 被引量:1
  • 7Garnero P,Sornay-Rendu E,Chapuy MC,et al.Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.J Bone Miner Res,1996,11:337-349. 被引量:1
  • 8Bonde M,Qvist P,Fledelius C,et al.Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps):follow-up on hormone replacement therapy and osteoporosis risk assessment.J Clin Endocrinol Metab,1995,80:864-868. 被引量:1
  • 9Gorai I,Taguchi Y,Chaki O,et al.Specific changes of urinary excretion of cross-linked N-telopeptides of type I collagen in pre-and postmenopausal women:correlation with other markers of bone turnover.Calcif Tissue Int,1997,60:317-322. 被引量:1
  • 10Chaki O,Yoshikata I,Kikuchi R,et al.The predictive value of biochemical markers of bone turnover for bone mineral density in postmenopausal Japanese women.J Bone Miner Res,2000,15:1537-1544. 被引量:1

共引文献16

同被引文献133

引证文献15

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部